Screener
Arcutis Biotherapeutics, Inc. ARQT Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s long-term debt?
- Arcutis Biotherapeutics, Inc. (ARQT) reported long-term debt of $101.95M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s long-term debt changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s long-term debt decreased by 4.8% year-over-year, from $107.05M to $101.95M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Arcutis Biotherapeutics, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude